TY  - GEN
AU  - Meel,Michaël H
AU  - de Gooijer,Mark C
AU  - Metselaar,Dennis S
AU  - Sewing,A Charlotte P
AU  - Zwaan,Kenn
AU  - Waranecki,Piotr
AU  - Breur,Marjolein
AU  - Buil,Levi C M
AU  - Lagerweij,Tonny
AU  - Wedekind,Laurine E
AU  - Twisk,Jos W R
AU  - Koster,Jan
AU  - Hashizume,Rintaro
AU  - Raabe,Eric H
AU  - Montero Carcaboso,Ángel
AU  - Bugiani,Marianna
AU  - Phoenix,Timothy N
AU  - van Tellingen,Olaf
AU  - van Vuurden,Dannis G
AU  - Kaspers,Gertjan J L
AU  - Hulleman,Esther
TI  - Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
SN  - 1557-3265
PY  - 2021///0914
KW  - Animals
KW  - Benzocycloheptenes
KW  - pharmacology
KW  - Biomarkers, Tumor
KW  - Blood-Brain Barrier
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Combined Modality Therapy
KW  - Diffuse Intrinsic Pontine Glioma
KW  - drug therapy
KW  - Disease Models, Animal
KW  - Drug Synergism
KW  - Epithelial-Mesenchymal Transition
KW  - Histone Deacetylase Inhibitors
KW  - Histone Deacetylases
KW  - metabolism
KW  - Humans
KW  - Immunohistochemistry
KW  - Mice
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins
KW  - antagonists & inhibitors
KW  - Receptor Protein-Tyrosine Kinases
KW  - Triazoles
KW  - Xenograft Model Antitumor Assays
KW  - Axl Receptor Tyrosine Kinase
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-19-3538
ER  -